- Disease area
- Laboratory services
This MAb recognises and interacts with human genistein. There is some cross-reactivity with daidzein (3.3 %), dihydrodaidzein (2.5 %), dihydrogenistein (0.4 %), and glycitein (0.3 %), but none with equol or O-DMA. It can be used for enzyme or fluorescent immunoassays, and is produced using BSA-conjugated human genistein as an immunogen.